Publication | Closed Access
Progression of Membranous Nephropathy to Acute Crescentic Rapidly Progressive Glomerulonephritis and Response to Pulse Methylprednisolone
19
Citations
0
References
1986
Year
Glomerular DiseaseRenal PathologyImmunologyAcute CrescenticPathologyGlomerulonephritisRenal FunctionIga GlomerulonephritisPulse MethylprednisoloneAcute Kidney InjuryChronic Kidney DiseaseSerum CreatinineAutoimmune DiseaseKidney FailureLupus NephritisMembranous NephropathySporadic ReportsEnd-stage Renal DiseaseUrologyRenal DiseaseNephritic SyndromeGlomerulopathyMedicineNephrologyKidney Research
There have been only sporadic reports of membranous nephropathy (MN) evolving into acute crescentic rapidly progressive glomerulonephritis (AC-RPGN). A patient with MN developed acute oliguric renal failure with a serum creatinine (SCr) of 8.4 mg/dl after 5 years of normal renal function. Biopsy now revealed epithelial crescent formation superimposed on MN. Pulse methylprednisolone resulted in significant improvement in renal function, with a SCr of 2.2 mg/dl at 6 months. No other favorable outcomes occurred in the 4 previous case reports of MN evolving into RPGN. AC-RPGN should be considered a treatable etiology of acute renal failure in the setting of MN.